Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension

Summary

The purpose of this study is to describe the long-term safety of a fixed combination product containing an alternative preservative, dosed once daily for 12 months, in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start

2009-07

Primary completion

2010-11

Completion

2010-11

Drugs

Indications